HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anders Osterborg Selected Research

zanolimumab

9/2010Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma.
6/2007Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anders Osterborg Research Topics

Disease

28B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2015 - 01/2002
25Neoplasms (Cancer)
01/2016 - 05/2002
12Multiple Myeloma
10/2012 - 01/2002
7Anemia
01/2014 - 01/2002
4Infections
01/2016 - 03/2004
4Disease Progression
01/2015 - 02/2005
4Mycosis Fungoides
06/2007 - 06/2003
3Neutropenia
01/2008 - 01/2003
2Leukemia
06/2012 - 02/2003
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2011 - 05/2006
2Lymphadenopathy
10/2010 - 04/2010
2Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
09/2010 - 04/2004
2Thrombocytopenia (Thrombopenia)
01/2009 - 01/2008
2Lymphoma (Lymphomas)
01/2008 - 06/2005
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
06/2007 - 06/2005
2Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2007 - 05/2002
2Febrile Neutropenia
04/2006 - 01/2003
1COVID-19
01/2020
1Communicable Diseases (Infectious Diseases)
01/2016
1Autoimmune Diseases (Autoimmune Disease)
01/2016
1Iron Overload
01/2014
1Iron Deficiencies
01/2014
1Carcinogenesis
01/2014
1Second Primary Neoplasms (Neoplasms, Second)
10/2011
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
09/2010
1T-Cell Lymphoma (Lymphoma, T Cell)
09/2010
1Breast Neoplasms (Breast Cancer)
01/2009
1Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
01/2009
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2009
1Cytopenia
01/2009
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2009
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
06/2007
1Hypersensitivity (Allergy)
03/2007

Drug/Important Bio-Agent (IBA)

14Alemtuzumab (Campath)FDA Link
11/2011 - 01/2002
10Monoclonal AntibodiesIBA
12/2014 - 01/2002
7fludarabineIBA
08/2014 - 01/2002
6Rituximab (Mabthera)FDA Link
01/2015 - 05/2006
5Proteins (Proteins, Gene)FDA Link
10/2012 - 06/2005
5ofatumumabFDA Link
11/2011 - 01/2010
4AntigensIBA
12/2014 - 02/2003
4Darbepoetin alfa (Aranesp)FDA Link
11/2012 - 10/2002
4HematinicsIBA
11/2012 - 02/2007
4epoetin betaIBA
11/2012 - 05/2002
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2011 - 01/2003
4Hemoglobins (Hemoglobin)IBA
06/2009 - 01/2002
4ErythropoietinFDA Link
06/2007 - 05/2002
4CytokinesIBA
01/2007 - 02/2004
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2012 - 01/2006
3Prednisone (Sone)FDA LinkGeneric
10/2011 - 01/2003
3Doxorubicin (Adriamycin)FDA LinkGeneric
10/2011 - 01/2003
3Vincristine (Oncovin)FDA LinkGeneric
10/2011 - 01/2003
2Agammaglobulinaemia Tyrosine KinaseIBA
01/2020 - 01/2015
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2016 - 12/2014
2ibrutinibIBA
01/2016 - 01/2015
2Phosphotransferases (Kinase)IBA
12/2014 - 02/2004
2FibromodulinIBA
08/2013 - 06/2005
2Telomerase (Telomerase Reverse Transcriptase)IBA
07/2013 - 02/2007
2Epoetin Alfa (Epogen)FDA Link
11/2012 - 06/2003
2VaccinesIBA
06/2012 - 02/2003
2EpitopesIBA
11/2011 - 02/2003
2zanolimumabIBA
09/2010 - 06/2007
2Interferon-alpha (Interferon Alfa)IBA
01/2008 - 01/2003
2Erythropoietin Receptors (Erythropoietin Receptor)IBA
06/2007 - 02/2007
2ThymidineIBA
06/2007 - 03/2007
2Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
04/2006 - 08/2002
2Ganciclovir (Cytovene)FDA LinkGeneric
04/2004 - 06/2003
2Dexamethasone (Maxidex)FDA LinkGeneric
04/2004 - 01/2003
1Bendamustine HydrochlorideFDA Link
01/2015
1Tyrosine (L-Tyrosine)FDA Link
12/2014
1IronIBA
01/2014
1Small Leucine-Rich ProteoglycansIBA
08/2013
1Sorafenib (BAY 43-9006)FDA Link
10/2012
1CaspasesIBA
10/2012
1Tyrosine Kinase InhibitorsIBA
10/2012
1PanobinostatIBA
07/2010
1Epirubicin (Ellence)FDA LinkGeneric
01/2009
1Fluorouracil (Carac)FDA LinkGeneric
01/2009
1Inosine Triphosphate (ITP)IBA
01/2009
1Cell Surface ReceptorsIBA
09/2008
1Pharmaceutical PreparationsIBA
04/2008
1Etodolac (Lodine)FDA LinkGeneric
04/2008
1Membrane Proteins (Integral Membrane Proteins)IBA
06/2007
1EnzymesIBA
03/2007
1Interleukin-12 (IL 12)IBA
03/2007
1continuous erythropoietin receptor activatorFDA Link
03/2007
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
03/2007
1Neoplasm Antigens (Tumor Antigens)IBA
02/2007
1Messenger RNA (mRNA)IBA
02/2007
1Alkylating AgentsIBA
04/2006
1purineIBA
04/2006

Therapy/Procedure

25Therapeutics
01/2020 - 01/2002
14Drug Therapy (Chemotherapy)
11/2012 - 10/2002
2Immunotherapy
04/2010 - 01/2009
2Radiotherapy
01/2009 - 06/2004
1Renal Dialysis (Hemodialysis)
01/2014
1Salvage Therapy
10/2010
1Intravenous Infusions
09/2010
1Complementary Therapies (Alternative Medicine)
03/2010
1Adjuvant Chemotherapy
01/2009
1Combination Drug Therapy (Combination Chemotherapy)
03/2007